Reduction in pulmonary artery pressures with use of sacubitril/valsartan

Pulmonary hypertension due to left heart disease (PH-LHD) frequently complicates heart failure with reduced ejection fraction (HFrEF). Specific therapies for PH have not offered an advantage in patients with PH-LHD. The combined angiotensin receptor blocker–neprilysin inhibitor (ARNI), sacubitril/va...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cardiol Cases
Main Authors: De Simone, Vincenzo, Guarise, Paola, Zanotto, Gabriele, Morando, Giorgio
Format: Artigo
Sprog:Inglês
Udgivet: Japanese College of Cardiology 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834956/
https://ncbi.nlm.nih.gov/pubmed/31719942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2019.08.006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker